Description
This induced pluripotent stem cell line was derived by using episomal vectors to reprogram dermal fibroblasts from a female Usher Syndrome type 2 patient. LEIi014-B is described as having a normal karyotype and compound heterozygous variants in the USH2A gene. Expression of OCT4, NANOG, TRA-1-81, SOX2, MYC and KLF4 in undifferentiated cells and in vitro spontaneous differentiation to endoderm, mesoderm and ectoderm have been reported. The donor of LEIi014-B is reported to be a sibling of the donor of LEIi010-A and LEIi010-B.
Tissue & Disease as reported
Genetic Information
Associated Publications
| Journal | Year | Article |
|---|---|---|
| Stem cell research | 2020 | Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene |
Line Custodianship
Cell Line Maintainer
Samuel McLenachan
Affiliated Institutions
- Lions Eye Institute, Nedlands, Australia
Cell Line Producer
Affiliated Institutions
- Lions Eye Institute, Nedlands, Australia